(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLINITEK NOVUS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLINITEK NOVUS

ST13

US500000085287952

Class

5

Filing

85287952

Registration

4230756

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

38

Latest update

03/15/2022

Trademark type

Word

Nice classes

5

Filing date

04/06/2011

Registration date

10/23/2012

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

03/15/2022

Last transaction

03/15/2022

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/09/2012

First use in commerce

01/31/2012

Drawing code

4

Owner type

03

Owner location

Tarrytown, NY

Examiner

SMITH, REBECCA

Law office

M10

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Siemens Healthcare Diagnostics Inc.
Siemens Healthcare Diagnostics Inc.

Representatives

Andrew Chien SIEMENS HEALTHCARE DIAGNOSTICS INC.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical reagent testsdiagnostic reagents for clinical medical laboratory use for the analysis of body fluids

Publications

History of USPTO decisions and trademark events.

38 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

03/15/2022

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/15/2022

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/15/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

03/15/2022

E89R

TEAS SECTION 8 & 9 RECEIVED

11/01/2021

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

10/23/2021

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

02/12/2018

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

02/12/2018

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

02/12/2018

E815

TEAS SECTION 8 & 15 RECEIVED

01/26/2018

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/23/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

11/26/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

10/23/2012

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED

09/19/2012

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/18/2012

REGV

LAW OFFICE REGISTRATION REVIEW COMPLETED

09/17/2012

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/16/2012

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/23/2012

IUAF

USE AMENDMENT FILED

08/21/2012

EISU

TEAS STATEMENT OF USE RECEIVED

08/21/2012

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

02/28/2012

EX1G

SOU EXTENSION 1 GRANTED

02/27/2012

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/27/2012

EXT1

SOU EXTENSION 1 FILED

01/30/2012

EEXT

SOU TEAS EXTENSION RECEIVED

01/30/2012

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/06/2011

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/12/2011

PUBO

PUBLISHED FOR OPPOSITION

07/12/2011

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/07/2011

ALIE

ASSIGNED TO LIE

06/06/2011

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/26/2011

XAEC

EXAMINER'S AMENDMENT ENTERED

05/26/2011

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/26/2011

GNEA

EXAMINERS AMENDMENT E-MAILED

05/26/2011

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/26/2011

DOCK

ASSIGNED TO EXAMINER

05/25/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/11/2011

NWAP

NEW APPLICATION ENTERED

04/09/2011

Continuous trademark protection

Get notified about every new filing that threatens CLINITEK NOVUS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.